跳至主要内容
临床试验/NCT03775031
NCT03775031Unknown不适用

Impact of Chemical Peels and Fractional Laser on IGF-1 Levels in Skin

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
IGF-1 Levels

研究概览

简要总结

The purpose of this study is to evaluate the impact of fractional laser versus chemical peels on IGF-1 levels in skin.

详细描述

This study is designed to assess the feasibility of using a fractional non ablative laser and chemical peels to wound skin, and thereby elicit a change in IGF-1. Our hypothesis is that fractional non ablative laser and a TCA chemical peel can induce similar effects as the fractional ablative laser at three months. In other words, our theory is that these approaches can stimulate the production of IGF-1 in older skin and restore UV damage repair and response mechanisms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects >55 years old
  • Fitzpatrick type I-II
  • Able to provide informed consent.
  • Cutaneous photodamage of 3 or above on the Larnier photodamage scale (see Appendix).

排除标准

  • Prior laser or peel treatment in the area evaluated in the current study in the past year.
  • Currently taking immunosuppressant medications known to interfere wound healing or anti-inflammatory medications (such as NSAIDs, or steroids).
  • Subjects who have underlying diseases that could alter wound healing response (such as Diabetes).
  • Currently taking insulin.
  • History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
  • History of abnormal scarring such as Keloids.
  • History of vitiligo.
  • Allergy or sensitivity or allergy to topical anesthesia
  • Inability to use sunscreen.
  • History of smoking in the last 10 years
  • Scar or prior surgery in the area of treatment.
  • Use of isotretinoin in the prior 6 months
  • Subjects who have bleeding disorders or who are taking anticoagulants

结局指标

主要结局

IGF-1 Levels

时间窗: 3 months

To quantify IGF-1 levels in skin

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Molly A. Wanner, MD

Dermatologist

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验